Goldman Sachs’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.54B | Buy |
11,065,214
+2,312,701
| +26% | +$324M | 0.18% | 93 |
|
|
2025
Q4 | $1.07B | Buy |
8,752,513
+1,630,711
| +23% | +$198M | 0.13% | 125 |
|
|
2025
Q3 | $791M | Buy |
7,121,802
+879,442
| +14% | +$100M | 0.1% | 184 |
|
|
2025
Q2 | $692M | Sell |
6,242,360
-543,837
| -8% | -$57.9M | 0.09% | 199 |
|
|
2025
Q1 | $760M | Sell |
6,786,197
-662,554
| -9% | -$68.4M | 0.12% | 150 |
|
|
2024
Q4 | $688M | Buy |
7,448,751
+305,163
| +4% | +$27.5M | 0.11% | 164 |
|
|
2024
Q3 | $599M | Sell |
7,143,588
-2,036,226
| -22% | -$155M | 0.1% | 201 |
|
|
2024
Q2 | $630M | Buy |
9,179,814
+3,989,275
| +77% | +$266M | 0.11% | 184 |
|
|
2024
Q1 | $380M | Sell |
5,190,539
-4,451,078
| -46% | -$342M | 0.07% | 297 |
|
|
2023
Q4 | $781M | Sell |
9,641,617
-1,456,702
| -13% | -$113M | 0.14% | 133 |
|
|
2023
Q3 | $832M | Buy |
11,098,319
+466,416
| +4% | +$35.9M | 0.18% | 105 |
|
|
2023
Q2 | $819M | Buy |
10,631,903
+144,579
| +1% | +$11.5M | 0.18% | 99 |
|
|
2023
Q1 | $870M | Buy |
10,487,324
+1,120,063
| +12% | +$92.8M | 0.2% | 84 |
|
|
2022
Q4 | $804M | Buy |
9,367,261
+1,404,678
| +18% | +$111M | 0.2% | 89 |
|
|
2022
Q3 | $491M | Sell |
7,962,583
-582,779
| -7% | -$36.7M | 0.12% | 135 |
|
|
2022
Q2 | $528M | Buy |
8,545,362
+1,242,886
| +17% | +$77M | 0.13% | 122 |
|
|
2022
Q1 | $434M | Buy |
7,302,476
+533,202
| +8% | +$34.1M | 0.09% | 196 |
|
|
2021
Q4 | $492M | Sell |
6,769,274
-801,385
| -11% | -$55.2M | 0.1% | 190 |
|
|
2021
Q3 | $529M | Sell |
7,570,659
-1,352,373
| -15% | -$95M | 0.11% | 162 |
|
|
2021
Q2 | $614M | Buy |
8,923,032
+5,648,535
| +173% | +$377M | 0.14% | 128 |
|
|
2021
Q1 | $212M | Buy |
3,274,497
+571,826
| +21% | +$36.9M | 0.05% | 352 |
|
|
2020
Q4 | $157M | Sell |
2,702,671
-592,916
| -18% | -$35.8M | 0.04% | 413 |
|
|
2020
Q3 | $208M | Sell |
3,295,587
-3,891,824
| -54% | -$270M | 0.06% | 320 |
|
|
2020
Q2 | $553M | Sell |
7,187,411
-1,152,131
| -14% | -$88.3M | 0.17% | 103 |
|
|
2020
Q1 | $623M | Sell |
8,339,542
-3,595,076
| -30% | -$248M | 0.22% | 82 |
|
|
2019
Q4 | $776M | Buy |
11,934,618
+2,103,489
| +21% | +$137M | 0.2% | 90 |
|
|
2019
Q3 | $623M | Sell |
9,831,129
-273,073
| -3% | -$17.9M | 0.18% | 92 |
|
|
2019
Q2 | $683M | Buy |
10,104,202
+391,040
| +4% | +$25.7M | 0.2% | 86 |
|
|
2019
Q1 | $631M | Buy |
9,713,162
+570,724
| +6% | +$37.9M | 0.19% | 92 |
|
|
2018
Q4 | $572M | Sell |
9,142,438
-606,828
| -6% | -$42.4M | 0.18% | 87 |
|
|
2018
Q3 | $753M | Buy |
9,749,266
+410,922
| +4% | +$31M | 0.19% | 83 |
|
|
2018
Q2 | $662M | Sell |
9,338,344
-3,445,174
| -27% | -$243M | 0.18% | 89 |
|
|
2018
Q1 | $964M | Buy |
12,783,518
+647,647
| +5% | +$51.5M | 0.25% | 65 |
|
|
2017
Q4 | $869M | Buy |
12,135,871
+870,571
| +8% | +$66.1M | 0.21% | 68 |
|
|
2017
Q3 | $913M | Buy |
11,265,300
+1,417,106
| +14% | +$108M | 0.22% | 61 |
|
|
2017
Q2 | $697M | Buy |
9,848,194
+794,271
| +9% | +$52.9M | 0.18% | 84 |
|
|
2017
Q1 | $615M | Buy |
9,053,923
+1,373,263
| +18% | +$96.6M | 0.17% | 99 |
|
|
2016
Q4 | $550M | Buy |
7,680,660
+2,222,718
| +41% | +$165M | 0.16% | 103 |
|
|
2016
Q3 | $432M | Sell |
5,457,942
-3,564,487
| -40% | -$290M | 0.13% | 128 |
|
|
2016
Q2 | $753M | Buy |
9,022,429
+2,237,867
| +33% | +$199M | 0.25% | 50 |
|
|
2016
Q1 | $623M | Sell |
6,784,562
-2,498,928
| -27% | -$225M | 0.2% | 72 |
|
|
2015
Q4 | $939M | Buy |
9,283,490
+477,535
| +5% | +$49.7M | 0.29% | 40 |
|
|
2015
Q3 | $865M | Sell |
8,805,955
-1,018,093
| -10% | -$113M | 0.29% | 41 |
|
|
2015
Q2 | $1.15B | Sell |
9,824,048
-9,739,392
| -50% | -$1.06B | 0.36% | 30 |
|
|
2015
Q1 | $1.92B | Sell |
19,563,440
-13,599
| -0.1% | -$1.38M | 0.62% | 10 |
|
|
2014
Q4 | $1.85B | Buy |
19,577,039
+3,142,434
| +19% | +$325M | 0.58% | 11 |
|
|
2014
Q3 | $1.75B | Sell |
16,434,605
-11,914,429
| -42% | -$1.17B | 0.56% | 13 |
|
|
2014
Q2 | $2.35B | Buy |
28,349,034
+7,972,186
| +39% | +$621M | 0.74% | 7 |
|
|
2014
Q1 | $1.44B | Buy |
20,376,848
+7,277,458
| +56% | +$571M | 0.47% | 19 |
|
|
2013
Q4 | $984M | Buy |
13,099,390
+2,739,818
| +26% | +$191M | 0.32% | 37 |
|
|
2013
Q3 | $651M | Buy |
10,359,572
+2,567,407
| +33% | +$153M | 0.24% | 61 |
|
|
2013
Q2 | $400M | Buy |
+7,792,165
| New | +$406M | 0.15% | 116 |
|
Other funds holding GILD
VCM
VPM
Goldman Sachs's GILD Position: Q1 2026 in Review
Goldman Sachs increased its Gilead Sciences (GILD) stake by 26% in Q1 2026, buying an estimated $324M and bringing the position to 11,065,214 shares worth $1.54B. The position accounts for 0.18% of the portfolio, ranked #93.
Goldman Sachs first reported a position in GILD in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.35B in Q2 2014. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Goldman Sachs held 11,065,214 shares of Gilead Sciences worth $1.54B as of Q1 2026.
- Goldman Sachs bought 2,312,701 Gilead Sciences shares in Q1 2026, an estimated $324M.
- Gilead Sciences made up 0.18% of Goldman Sachs's portfolio in Q1 2026, its #93 holding.
- Goldman Sachs first reported a position in Gilead Sciences in Q2 2013 and has held it in 52 quarters since.
- Goldman Sachs's Gilead Sciences position peaked at $2.35B in Q2 2014.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.